newsfilter
← Latest News
FDA Approved Drugs·

Approval of Skyclarys, Nda #216718 (Type 1 - New Molecular Entity)

Approval Date: 02/28/2023; Drug Name: Skyclarys, Nda #216718; Active Ingredients: OMAVELOXOLONE; Company: Reata Pharmaceuticals Inc; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 216718

Company
REATA PHARMACEUTICALS INC
Keywords
REATA PHARMACEUTICALS INC